Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
17 Março 2021 - 8:31AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2021
ZHONGCHAO INC.
(Translation of Registrant's name into English)
Nanxi Creative Center, Suite 218
841 Yan’an Middle Road
Jing’An District, Shanghai, China
200040
Tel: 021-32205987
(Address of Principal Executive Office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant
is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
CONTENTS
On March 17, 2021,
Zhongchao Inc. (the “Company”) issued a press release announcing the renewal of its partnership with the China Association
for Health Promotion and Education and GlaxoSmithKline(china) Investment Limited to continue the medical education program “Pulmonary
Arterial Hypertension Online Course- Connections with Famous Hospitals” (“PAH Project”) in 2021.
A copy of this press
release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
This report does not
constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the
securities laws of any such state or jurisdiction.
Financial Statements and Exhibits.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned,
hereunto duly authorized.
|
|
Zhongchao Inc.
|
|
|
|
|
|
|
By:
|
/s/ Weiguang Yang
|
|
|
Name:
|
Weiguang Yang
Chief Executive Officer
|
|
|
Title:
|
Date: March 17, 2021
Zhongchao (NASDAQ:ZCMD)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
Zhongchao (NASDAQ:ZCMD)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025
